Physician profile
Sandra K Sullivan
NPI 1386733574
$7,252.12
in general payments reported to CMS, 2019-2025
17 companies · $1,562 in 2025
The $1,562 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $897 · 2022: $2,655 · 2023: $1,823 · 2024: $314 · 2025: $1,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,878 · Food and Beverage: $1,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,877.67 |
| Food and Beverage | $1,822.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,913.38 | 2021-2024 | Cardiomems |
| Medtronic, INC. | $1,588.96 | 2023-2025 | Harmony |
| Boston Scientific Corporation | $994.66 | 2022-2025 | Bodyguardian |
| Cvrx, INC. | $878.53 | 2021-2023 | Barostim Neo System |
| Novo Nordisk INC | $367.00 | 2023-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $241.98 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.20 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $202.35 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $192.93 | 2021-2023 | Lifevest |
| Amgen INC. | $122.76 | 2023 | Repatha |
| Biotronik INC. | $120.09 | 2022 | |
| Cardiva Medical, INC. | $111.78 | 2021 | |
| Esperion Therapeutics, INC. | $100.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $93.47 | 2024 | Assure Wcd |
| Vital Connect, INC | $72.24 | 2024 | Vitalpatch Rtm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.99 | 2021 | |
| Halozyme INC | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.